WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001080855) TELOMERASE INHIBITORS AND METHODS OF THEIR USE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/080855    International Application No.:    PCT/US2001/013419
Publication Date: 01.11.2001 International Filing Date: 26.04.2001
Chapter 2 Demand Filed:    26.11.2001    
IPC:
A61K 31/352 (2006.01), A61K 31/47 (2006.01)
Applicants: GERON CORPORATION [US/US]; 230 Constitution Drive Menlo Park, CA 94025 (US) (For All Designated States Except US).
CHIN, Allison, C. [GB/GB]; (US) (For US Only).
TOLMAN, Richard, L. [US/US]; (US) (For US Only).
GRYAZNOV, Sergei [RU/US]; (US) (For US Only).
MATRAY, Tracy [US/US]; (US) (For US Only)
Inventors: CHIN, Allison, C.; (US).
TOLMAN, Richard, L.; (US).
GRYAZNOV, Sergei; (US).
MATRAY, Tracy; (US)
Agent: BANAIT, Narinder, S.; Geron Corporation 230 Constitution Drive Menlo Park, CA 94025 (US).
SCHIFF, J., Michael; Geron Corporation 230 Constitution Drive Menlo Park, CA 94025 (US)
Priority Data:
60/200,171 27.04.2000 US
Title (EN) TELOMERASE INHIBITORS AND METHODS OF THEIR USE
(FR) INHIBITEURS DE LA TELOMERASE ET PROCEDES POUR LES UTILISER
Abstract: front page image
(EN)Substituted flavone compounds, compositions, and methods of inhibiting telomerase activity and treatment of telomerase mediated conditions or diseases are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of conditions or diseases mediated by telomerase activity, such as in the treatment of cancer.
(FR)L'invention concerne des composés de flavone substitués et des compositions, ainsi que des procédés permettant d'hiniber inhiber l'activité de la télomérase et de traiter des troubles ou des maladies induits par la télomérase. Les procédés, composés et compositions de l'invention peuvent être employés seuls, ou en combinaison avec d'autres agents actifs pharmacologiquement dans le traitement de troubles ou de maladies induits par l'activité de la télomérase, comme dans le traitement du cancer.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)